DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
02-27
德康醫療-1.17%盤後

DJ DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. $(DXCM)$ slid 2.34% to $87.81 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.59% to 5,861.57 and Dow Jones Industrial Average falling 0.45% to 43,239.50.

DexCom Inc. closed 38.16% short of its 52-week high of $142.00, which the company achieved on March 26th.

The stock underperformed when compared to some of its competitors Thursday, as Abbott Laboratories $(ABT)$ fell 0.07% to $135.87 and Insulet Corp. $(PODD)$ fell 1.31% to $267.09.

Trading volume (2.5 M) remained 1.1 million below its 50-day average volume of 3.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 27, 2025 16:56 ET (21:56 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

no data

沒有相關數據

如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”